CSCTC was founded in 2010 for the investigational use of stem cells deployments for degenerative conditions. The source of the cells is actually stromal vascual fraction which is a protein rich segment of processed adipose tissue. Stromal vascular fraction contains a mononuclear cell line (predominantly autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important growth factors that turn on the stem cells and promote their activity. We have high numbers of viable cells and we are trying to learn which diseases are most appropriate to treat and which deployment methods are most effective. We are growing and continue to use our methods to deploy cells anywhere in the body to provide care for various degenerative conditions. CSCTC employs a clinical research coordinator to protect our valuable data and our vision is to perfect our treatments and ultimately teach them to other physicians around the world.